98%
921
2 minutes
20
As the integration of artificial intelligence (AI) into radiology workflows continues to evolve, establishing standardized processes for the evaluation and deployment of AI models is crucial to ensure success. This article outlines the creation of a Radiology AI Council at a large academic center and subsequent development of framework in the form of a rubric to formalize the evaluation of radiology AI models and onboard them into clinical workflows. The rubric aims to address the challenges faced during the deployment of AI models, such as real-world model performance, workflow implementation, resource allocation, return on investment, and impact to the broader health system. Using this comprehensive rubric, the council aims to ensure that the process for selecting AI models is both standardized and transparent. This article outlines the steps taken to establish this rubric, its components, and the initial results from evaluation of 13 models over an 8-month period. We emphasize the importance of holistic model evaluation beyond performance metrics, and transparency and objectivity in AI model evaluation, with the goal of improving the efficacy and safety of AI models in radiology.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jacr.2025.05.016 | DOI Listing |
Environ Sci Process Impacts
September 2025
Aix Marseille Univ., CNRS, LCE, Marseille, France.
Surfactant-rich aqueous media are common in natural environments. The sea surface microlayer and sea spray droplets are good examples and are also frequently markedly enriched in organic pollutants. This study focuses on the degradation kinetics of organic pollutants initiated by the hydroxyl radical in such surfactant-rich environments.
View Article and Find Full Text PDFArthritis Rheumatol
September 2025
Washington DC Veterans Affairs Medical Center; Georgetown University, Washington, DC, USA.
Objective: To evaluate the clinical characteristics, social deprivation, insurance coverage, and medication use across regional subsets of patients with psoriatic arthritis (PsA) in the US.
Methods: A cross-sectional study of PsA patients in the Rheumatology Informatics System for Effectiveness (RISE) registry between January 2020 and March2023 was conducted. Distribution of high disease activity (HDA - RAPID3>12), high comorbidity (RxRisk ≥90 percentile), high Area Deprivation Index (ADI ≥80), insurance coverage, prednisone ≥10mg daily, and all DMARD therapies across geographic regions were evaluated.
Drug Alcohol Rev
September 2025
The Prescription Drug Misuse Education and Research (PREMIER) Center, University of Houston, Houston, Texas, USA.
Introduction: Buprenorphine is effective for opioid use disorder (OUD), yet adherence remains suboptimal. This study aimed to identify adherence trajectories, explore their predictors, and assess their association with opioid overdose risk and healthcare costs.
Methods: A retrospective cohort study was conducted using the Merative MarketScan Commercial Database, which includes a nationally representative sample of individuals with private, employer-sponsored health insurance in the United States.
Stroke
September 2025
Department of Neurology, Vagelos College of Physicians and Surgeons, Columbia University, New York. (F.C.P., M.R., M.S., A.K., S.G., S.A., S.P., J.C., D.J.R.).
Background: Major ABO-incompatible platelet transfusions are associated with poor intracerebral hemorrhage (ICH) outcomes, yet drivers for this relationship remain unclear. Brain magnetic resonance imaging (MRI) ischemic lesions after ICH are neuroimaging biomarkers of secondary brain injury and are associated with poor outcomes. Given that ABO-incompatible platelet transfusions can induce immune complex formation, thrombo-inflammation, and endothelial barrier disruption, factors that could exacerbate cerebral ischemia, we explored whether major ABO-incompatible platelet transfusions are risk factors for ischemic lesions on brain MRI after ICH.
View Article and Find Full Text PDF